Literature DB >> 24792491

FRK suppresses the proliferation of human glioma cells by inhibiting cyclin D1 nuclear accumulation.

Lei Hua1, Ming Zhu, Xu Song, Jun Wang, Zhen Fang, Chunting Zhang, Qiong Shi, Wenjian Zhan, Lei Wang, Qingming Meng, Xiuping Zhou, Rutong Yu.   

Abstract

The Fyn related kinase (FRK) is a noteworthy member of the Src non-receptor tyrosine kinase family for its distinctive tumor suppressive function. Recently, we have shown that FRK plays a protective role against the progression of glioma by suppressing cell migration and invasion. However, it is unclear whether the cell growth of glioma is also regulated by FRK and by which mechanism FRK alters its specific biological functions. In the current study, we found that FRK over-expression significantly suppressed the proliferation of glioma cells. In contrast, FRK knockdown by siRNA promoted glioma cell growth. In addition, FRK over-expression caused G1 phase arrest as well as apoptosis of glioma cells. Further investigation disclosed that FRK-induced G1 arrest was accompanied by down-regulation of hyperphosphorylated retinoblastoma protein (pRb), which led to the consequent suppression of E2F1. More importantly, we found that over-expression of FRK inhibited proper cyclin D1 accumulation in the nucleus of proliferating cells. Taken together, our results demonstrate a combined mechanism for the anti-proliferative effects of FRK by inhibiting cyclin D1 nucleus accumulation and pRb phosphorylation in glioma cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24792491     DOI: 10.1007/s11060-014-1461-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  41 in total

1.  Hormone-dependent nuclear localization of the tyrosine kinase iyk in the normal human breast epithelium and loss of expression during carcinogenesis.

Authors:  G Berclaz; H J Altermatt; V Rohrbach; E Dreher; A Ziemiecki; A C Andres
Journal:  Int J Cancer       Date:  2000-03-15       Impact factor: 7.396

2.  Role of the Bsk/Iyk non-receptor tyrosine kinase for the control of growth and hormone production in RINm5F cells.

Authors:  C Annerén; M Welsh
Journal:  Growth Factors       Date:  2000       Impact factor: 2.511

3.  New functional activities for the p21 family of CDK inhibitors.

Authors:  J LaBaer; M D Garrett; L F Stevenson; J M Slingerland; C Sandhu; H S Chou; A Fattaey; E Harlow
Journal:  Genes Dev       Date:  1997-04-01       Impact factor: 11.361

4.  EdU, a new thymidine analogue for labelling proliferating cells in the nervous system.

Authors:  Fatemah Chehrehasa; Adrian C B Meedeniya; Patrick Dwyer; Greger Abrahamsen; Alan Mackay-Sim
Journal:  J Neurosci Methods       Date:  2008-10-18       Impact factor: 2.390

Review 5.  Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases.

Authors:  Michael S Serfas; Angela L Tyner
Journal:  Oncol Res       Date:  2003       Impact factor: 5.574

Review 6.  Genetic pathways to primary and secondary glioblastoma.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

7.  Rak functions as a tumor suppressor by regulating PTEN protein stability and function.

Authors:  Eun-Kyoung Yim; Guang Peng; Hui Dai; Ruozhen Hu; Kaiyi Li; Yiling Lu; Gordon B Mills; Funda Meric-Bernstam; Bryan T Hennessy; Rolf J Craven; Shiaw-Yih Lin
Journal:  Cancer Cell       Date:  2009-04-07       Impact factor: 31.743

Review 8.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

9.  Cloning of FRK, a novel human intracellular SRC-like tyrosine kinase-encoding gene.

Authors:  J Lee; Z Wang; S M Luoh; W I Wood; D T Scadden
Journal:  Gene       Date:  1994-01-28       Impact factor: 3.688

Review 10.  Src signaling in cancer invasion.

Authors:  Marcello Guarino
Journal:  J Cell Physiol       Date:  2010-04       Impact factor: 6.384

View more
  7 in total

1.  Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation.

Authors:  Edward T Bagu; Sayem Miah; Chenlu Dai; Travis Spriggs; Yetunde Ogunbolude; Erika Beaton; Michelle Sanders; Raghuveera K Goel; Keith Bonham; Kiven E Lukong
Journal:  Oncotarget       Date:  2017-02-14

2.  Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer.

Authors:  Qingyu Xiao; Yidi Sun; Albert Dobi; Shiv Srivastava; Wendy Wang; Sudhir Srivastava; Yuan Ji; Jun Hou; Guo-Ping Zhao; Yixue Li; Hong Li
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

3.  miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK-PTEN axis.

Authors:  Zhi-Fei Jing; Jian-Bin Bi; Ze-Liang Li; Xian-Kui Liu; Jun Li; Yu-Yan Zhu; Xiao-Tong Zhang; Zhe Zhang; Zhen-Hua Li; Chui-Ze Kong
Journal:  Onco Targets Ther       Date:  2019-04-10       Impact factor: 4.147

Review 4.  Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia.

Authors:  Justin F Creeden; Khaled Alganem; Ali S Imami; Nicholas D Henkel; F Charles Brunicardi; Shi-He Liu; Rammohan Shukla; Tushar Tomar; Faris Naji; Robert E McCullumsmith
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

5.  FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition.

Authors:  Yetunde Ogunbolude; Chenlu Dai; Edward T Bagu; Raghuveera Kumar Goel; Sayem Miah; Joshua MacAusland-Berg; Chi Ying Ng; Rajni Chibbar; Scott Napper; Leda Raptis; Frederick Vizeacoumar; Franco Vizeacoumar; Keith Bonham; Kiven Erique Lukong
Journal:  Oncotarget       Date:  2017-12-06

6.  The role of Rak in the regulation of stability and function of BRCA1.

Authors:  Jung-Lye Kim; Geun-Hyoung Ha; Loredana Campo; Mitchell F Denning; Tarun B Patel; Clodia Osipo; Shiaw-Yih Lin; Eun-Kyoung Breuer
Journal:  Oncotarget       Date:  2015-10-14

7.  TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.

Authors:  Yuta Yamada; Naoki Kimura; Ken-Ichi Takayama; Yusuke Sato; Takashi Suzuki; Kotaro Azuma; Tetsuya Fujimura; Kazuhiro Ikeda; Haruki Kume; Satoshi Inoue
Journal:  Cancer Sci       Date:  2020-01-20       Impact factor: 6.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.